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Abstract Acute undifferentiated fever (AUF) poses a
diagnostic challenge due to the variety of possible aeti-
ologies. While the majority of AUFs resolve spontane-
ously, some cases become prolonged and cause signifi-
cant morbidity and mortality, necessitating improved di-
agnostic methods. This study evaluated the utility of
deep sequencing in fever investigation. DNA and RNA
were isolated from plasma/sera of AUF cases being in-
vestigated at Cairns Hospital in northern Australia, in-
cluding eight control samples from patients with a con-
firmed diagnosis. Following isolation, DNA and RNA
were bulk amplified and RNA was reverse transcribed
to cDNA. The resulting DNA and cDNA amplicons
were subjected to deep sequencing on an Illumina
HiSeq 2000 platform. Bioinformatics analysis was per-
formed using the program Kraken and the CLC
assembly-alignment pipeline. The results were compared
with the outcomes of clinical tests. We generated be-
tween 4 and 20 million reads per sample. The results
of Kraken and CLC analyses concurred with diagnoses
obtained by other means in 87.5 % (7/8) and 25 %
(2/8) of control samples, respectively. Some plausible
causes of fever were identified in ten patients who
remained undiagnosed following routine hospital inves-
tigations, including Escherichia coli bacteraemia and
sc rub typhus tha t e luded conven t iona l t e s t s .
Achromobacter xylosoxidans, Alteromonas macleodii
and Enterobacteria phage were prevalent in all samples.
A deep sequencing approach of patient plasma/serum
samples led to the identification of aetiological agents
putatively implicated in AUFs and enabled the study of
microbial diversity in human blood. The application of
this approach in hospital practice is currently limited by
sequencing input requirements and complicated data
analysis.
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Introduction
Acute undifferentiated fever (AUF) is caused by a variety of
causes, producing a range of clinical manifestations with acute
fever as a unifying symptom. Most clinicians and researchers
define acute fever as evidence of raised body temperature to
≥38 °C for ≤3 weeks, without detection of systemic disease or
the focus of infection or inflammation after initial clinical
evaluation and basic laboratory investigations [1]. This condi-
tion poses a diagnostic challenge for clinicians due to non-
specific clinical features and the indistinctive profile of routine
blood tests.Without a specific aetiological diagnosis, the treat-
ment of AUF is often based on an ‘educated guess’ or a
syndromic approach that often leads to inappropriate treat-
ment [2, 3].
It has long been known that infection is the main cause of
fever, particularly in the acute stage. Unfortunately, there are
hundreds of possible aetiologies of fever, such that conven-
tional diagnostic tools are often either unavailable or restricted
to a subset of the ‘most likely’ infectious agents due to the
high costs associated with laboratory testing. The limitation of
the current diagnostic approach causes a significant proportion
of fever to go undiagnosed. Indeed, the frequencies of undi-
agnosed AUFs in Asian tropical countries ranges from 8 to
80 % [1].
The wide availability of nucleic acid [i.e. polymerase chain
reaction (PCR)-based] assays in clinical laboratories provides
sensitive and specific detection of pathogens. However, while
techniques such as multiplex PCR can provide simultaneous
detection of multiple pathogens, this approach is impractical
for more than a handful of pathogens in any one assay [4, 5]
and is not capable of detecting novel pathogens [6].
Diagnostic microarrays can expand detection capacity consid-
erably, allowing simultaneous detection of tens of pathogens
or more [7, 8], but these too are limited for the detection of
novel or emerging pathogens [9].
The advent of next-generation sequencing (NGS) [10] pro-
vides a basis for unbiased identification of infectious agents
associated with AUF, as well as the capacity to identify novel
and emerging pathogens [9, 11, 12]. This study aimed to eval-
uate the practical use of NGS technology as a diagnostic tool
for the identification of infectious agents causing fever. This
method is referred to as metagenomic deep sequencing and
has been used in previous studies to determine the agents
responsible for dengue-like illnesses [9] and acute
haemorrhagic fever [13].
Materials and methods
Sample collection
We collected 40 plasma/serum samples from patients who
presented to Cairns Hospital, a tertiary hospital in Cairns,
Far North Queensland, Australia (16.9256° S, 145.7753° E).
The inclusion criteria included patients aged 16 to 65 years
who had raised temperature of ≥38 °C or history of fever with
feeling cold or shivering for up to 21 days with no evident
focus of infection and no obvious cause of fever after initial
clinical, radiology and laboratory evaluation; this included
tests for which results were normally reported within 6 h from
admission. Thus, a specific diagnosis at the time of patient
recruitment was unavailable. Subsequent investigation(s) de-
termined by the attending doctors ascertained an aetiological
diagnosis in a subset of study participants (control subjects),
while other participants (test subjects) remained undiagnosed
(Fig. 1).
Sample preparation and sequencing
DNA was isolated from 200 μl of plasma/serum using the
QIAamp® DNA Mini Kit (Qiagen), while RNAwas isolated
from 250 μl of sample mixed with 750 μl of TRIzol® LS
reagent (Life Technologies), as per the manufacturer’s proto-
col. Each sample preparation was performed in duplicate.
Following RNA isolation, genomic DNAwas removed from
RNA samples using DNase I, Amplification Grade (Sigma
Aldrich). Amplification of DNA and RNA was conducted
according to the SeqPlex Enhanced DNA Amplification Kit
and the SeqPlex RNAAmplification Kit (Sigma Aldrich) pro-
tocols, resulting in double-stranded DNA and cDNA
amplicons, respectively. The GenElute PCR Clean-Up Kit
(Sigma-Aldrich) was used for the purification of products
from the SeqPlex DNA and RNA amplification kits. The
quantity, size and purity of DNA/cDNA amplicons were de-
termined using gel electrophoresis (1.5 % agarose) and a
NanoDrop 2000 spectrophotometer (Thermo Scientific), as
requested by the commercial sequencing service used for the
study: the Australian Genome Research Facility (AGRF). The
samples that passed AGRF quality assessment were processed
into library preparations using the TruSeq Nano DNA Library
Preparation Kit protocol (Illumina). Paired-end (PE) 100-bp
sequencing was conducted using an Illumina HiSeq 2000
instrument.
Bioinformatics analysis
Identification of pathogens associated with AUF was per-
formed on two cloud computing servers: BaseSpace®
(Illumina) and CLC Genomics Workbench (Qiagen) (Fig. 2).
First, the raw sequence data obtained from AGRF were
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uploaded onto the BaseSpace® server; then, human sequences
in each dataset were identified by alignment to the human
reference genome (hg19) using the program SNAP version
1.0beta.14 [14] and removed. The remaining sequences were
then classified using the default parameters of the program
Kraken version 0.10.4-beta [15], based on their homology
with organisms in the MiniKraken 20140330 database, which
contains a collection of complete bacterial, archaeal and viral
genomes available from the National Center for
Biotechnology Information (NCBI) RefSeq database.
Any non-human reads not classified by Kraken were
imported to the CLC Genomics Workbench server. The qual-
ity of the sequence data was examined using the FastQC tool
[16]. The reads were then processed using the CLC Trim
Sequences tool to remove adapters, low quality bases, ambig-
uous nucleotides, terminal nucleotides (25–35 nucleotides
from the 5’ end) and short sequences (less than 24 nucleo-
tides). Then, reads were mapped and filtered a second time
using the CLC read mapper program to the human reference
genome (hg19). All remaining reads were assembled using the
CLC De Novo Assembly tool. Assembled contigs were com-
pared with the NCBI non-redundant database using the Basic
Local Alignment Search Tool (BLAST) [17]. The BLASTn
program optimised for highly similar sequences (megablast)
was used to search nucleotide databases for sequence(s) that
matched a nucleotide query. The nearest matching sequence
(e-value threshold ≤10−5) was accepted as the most likely
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Fig. 1 Flow chart of patient selection. Definitions: Acute fever is an
increase of body temperature to 38 °C or more for a period of 21 days
or less. Initial investigations refer to comprehensive clinical assessment
and basic laboratory and radiology tests; this included tests that are
normally reported within 6 h from admission. Comprehensive clinical
assessment includes complete history taking and thorough physical
examination. Basic laboratory tests usually include complete blood
count and urinalysis. Basic radiology tests could include chest X-ray,
abdomen and pelvic X-ray, and ultrasonography. Fever with obvious
likely diagnosis is any case of fever with definitive diagnosis
immediately after initial investigations. This includes fever cases with
an obvious focus of infection or local inflammation, such as
community-acquired pneumonia, urinary tract infection, skin and soft
tissue infection, bone and dental infection, pelvic inflammatory disease
and intra-abdominal infection. Acute undifferentiated fever is any case of
acute fever with unclear aetiology and the results of initial investigations
are not conclusive in achieving a diagnosis. Thus, the condition is
characterised by a requirement for further investigation to explain the
cause of fever and to consider differential diagnoses. Rational diagnostic
investigations are further tests as judged by an attending doctor to deter-
mine the cause of fever, such as further serology, cerebrospinal fluid
analysis and/or advanced radiology tests [computed tomography (CT)
scan, magnetic resonance imaging (MRI)]. Samples were collected from
both groups of participants (diagnosed subjects and undiagnosed sub-
jects) for fever investigation using the deep sequencing approach
 
Secondary analysis on  
CLC Genomics Workbench 
Primary analysis on BaseSpace  
Human reads 
Non-human 
reads 
Kraken 
classification 
 
Raw 
data 
Reference 
mapping 
Human 
reads 
Non-human 
reads 
Assembly 
BLAST 
alignment 
 
Raw 
data 
Quality 
checking Trimming 
Contigs 
F
ilt
er
in
g
 
F
ilt
er
in
g
 
®
Fig. 2 Analysis workflow. Primary and secondary analyses were
performed sequentially for all samples and performed in parallel for the
purpose of validation. Sequential analysis means that all reads were
uploaded to the BaseSpace® server, followed by analysis of non-human
reads not classified by Kraken in the CLC server. Validation of next-
generation sequencing (NGS) analysis was performed on positive control
samples only by analysing all reads using the BaseSpace® and CLC
servers in parallel
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homolog for each contig. As an independent assessment of
Kraken, we also ran all reads from the control samples through
the CLC workflow without prior SNAP filtering/Kraken
analysis.
The results of primary (Kraken) and secondary (CLC) anal-
yses were screened for pathogens known to cause prominent
symptoms in infected patients. Following this, the probable
causative agents were listed according to the number of reads
(from largest to smallest) obtained from the primary analysis.
The BLAST e-value was reported if the pathogen was detect-
ed in the secondary analysis as well. When the sequencing
was performed on duplicate samples, only the results from
the sample that produced the largest sequencing dataset were
reported. Finally, the results of bioinformatics analysis in con-
junction with supporting clinical data and laboratory findings
were used to inform diagnosis.
Results
Of the 40 DNA and cDNA samples that we prepared in du-
plicate, only 22 samples from 17 participants (eight samples
from seven control subjects and 14 samples from ten test sub-
jects) met the quantity and quality requirements for deep se-
quencing. From these, between 4 and 20 million reads per
sample were generated. The majority (43.67–94.38 %) of
these reads were of human origin, with only a small proportion
of non-human reads being classified by Kraken. The number
of viral, bacterial and archaeal species reported by Kraken
varied considerably, from 146 to 505 species per sample
(Fig. 3).
The secondary analysis facilitated further classification of
reads left unclassified by Kraken. Analysis with the CLC
Genomics Workbench revealed that Kraken-unclassified
reads still contained human sequences, accounting for 18.9–
81.7 % of the total contigs in each sample. Non-host contigs
classified by BLAST analysis included viruses, bacteria and
other organisms, such as archaea (e.g. Sulfolobus sp.), fungi
(e.g. Saccharomyces sp., Cryptococcus sp., Penicillium sp.),
algae (e.g. Navicula gregaria), plants (e.g. rice, tomato, grain,
tobacco), protozoa (e.g. Toxoplasma gondii, Plasmodium
berghei), human parasites (e.g. roundworm, tapeworm, pin-
worm) and larger animals (e.g. snail, fish, rat, monkey, orang-
utan, gorilla). Following analysis, 2.7–29.5 % of the total
contigs in each sample remained unclassified (Fig. 4).
Table 1 compares the outcomes of hospital investigations
and NGS analyses. Confirmation of diagnosis by NGS means
that at least one read or one contig was assigned to the infec-
tious organism. Kraken analysis confirmed the specific diag-
noses obtained by other means in 7/8 (87.5 %) of control
samples, whereas CLC analysis only concurred with the re-
sults of clinical tests in 2/8 (25 %) of control samples, both of
whom had dengue virus 1 infection: patient ID# 005 and 017.
The CLC reference mapping aligned the position of the virus
contigs with the dengue virus 1 reference genome (accession
number: NC_001477.1). In the first dengue case (ID# 005),
the CLC analysis constructed eight contigs of dengue virus 1
with length 166 to 1328 bp, whereas in the second dengue
case (ID# 017), only one contig of dengue virus 1 was avail-
able, with a length of 217 bp (Fig. 5).
Our deep sequencing approach identified some plausible
causes of fever in 80 % (8/10) of the test subjects (ID# 002,
011, 014, 019, 027, 029, 030, 039) who remained
Fig. 3 Summary of Kraken
analysis on reads generated by
Illumina HiSeq 2000. cDNA
samples from patient ID# 002,
017 and 019 were prepared and
sequenced in duplicate (sample
IDs 2c1, 2c2, 17c1, 17c2, 19c1
and 19c2)
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undiagnosed after routine hospital investiagations (Table 2).
In particular, our analyses confirmed the aetiological diagno-
sis of two AUF cases that eluded conventional investigation
methods. A high number of Escherichia coli sequences were
detected in the sample of a fatal diarrhoea case with a sterile
blood culture (patient ID# 002) and Orientia tsutsugamushi
was detected in a PCR-negative patient with clinical features
of scrub typhus (patient ID# 011). Furthermore, the results of
deep sequencing highlighted a surprising microbial diversity
in a ‘sterile’ environment; that is, human blood. Table 3 shows
61 organisms that were present in all samples and their relative
abundance.
Discussion
To date, there has been little research undertaken to investigate
the application of NGS in fever investigation, possibly due to
the relatively high costs and complex methods of sample prep-
aration and data analysis. Since the costs associated with NGS
are proportional to the amount of sequence data generated per
sequencing run, one way to reduce the sequencing costs is by
requesting the minimum amount of sequence data without
compromising the sensitivity of detection of the pathogen.
This can be achieved, for instance, by reducing human DNA
contamination to maximise the yield of pathogen sequences.
Fig. 4 Summary of CLC
Genomics analysis on Kraken-
unclassified reads *BLASTn
optimised for highly similar
sequences (megablast) was
performed to search the
homology between query
sequences and reference
sequences in the database. If
multiple significant similarities
matched with a single species,
only the highest scoring hit was
reported. A similarity was
considered significant at
e-value ≤10−5
Table 1 Validation of diagnosis in eight samples originating from seven control subjects
Patient
(sample) ID
Diagnosis Results from conventional
hospital diagnostic approach
Time of sample collection for
NGS study
Detection of pathogen in NGS
analysis
Kraken – no. of
reads
CLC – no. of
contigs
005 (5c)a Dengue PCR+, NS1+, IgM− Fever day-4 Yes – 105,738 Yes – 8
010 (10)b Leptospirosis IgM+ Fever day-9, antibiotics day-3 Yes – 1 No
017 (17c1)a Dengue NS1+, IgM+ Fever day-8 Yes – 64 Yes – 1
017 (17c2)a Dengue NS1+, IgM+ Fever day-8 Yes – 4 No
020 (20c)a Dengue NS1+, IgM+ Fever day-6 Yes – 25 No
024 (24c)a Measles PCR+, IgM+ Fever day-4 No No
031 (31c)a Dengue PCR−, NS1+, IgM+ Fever day-8 Yes – 6 No
032 (32)b S. pyogenes bacteraemia Blood culture+ Fever day-2, antibiotics day-1 Yes – 1 No
a Sequencing was performed on cDNA samples
b Sequencing was performed on DNA samples
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Most human DNA is cellular in origin; thus, cell-free samples
such as plasma and serum are expected to have a higher ratio
of pathogen/human DNA than whole blood.
Previous studies have used deep sequencing to facilitate the
discovery of novel viruses in plasma/serum samples [13,
18–21], but the use of such samples in the present study posed
a challenge. Despite achieving low-level human DNA con-
tamination, which is necessary to keep sequencing costs min-
imal, the plasma and serum samples contained very low quan-
tity and quality of nucleic acids. Commercial sequencing ser-
vices that we contacted required at least 100 ng of DNA/RNA
per sample, which is challenging to achieve from plasma/
serum volumes typically collected for routine blood diagnosis.
The attempt to meet the minimum input requirement for se-
quencing necessitated amplification, which could introduce
biases during sequencing [22]. Furthermore, every additional
step carried out during sample preparation is a potential source
of contamination, and might cause further degradation of the
nucleic acids.
While the primary aim of this study was to evaluate the use
of NGS in detecting pathogens associated with AUFs, our
data provide an insight into the microbial diversity in human
blood (Table 3). We presumed that the origins of these micro-
organisms are either from experimental reagents (i.e.
Achromobacter xylosoxidans, Alteromonas macleodii,
enterobacteria phage), cross-contamination from one sample
to another (i.e. hepatitis C virus, dengue virus), from the skin
during phlebotomy (i.e. Propionibacterium acnes,
Staphylococcus epidermidis) or from the blood itself [i.e.
torque teno midi virus (TTMDV), human herpesvirus 4].
Achromobacter xylosoxidans can be found in water envi-
ronments and has been isolated from both immunocompetent
and immunocompromised patients with bacteraemia, chronic
otitis media, meningitis, urinary tract infections, abscesses,
osteomyelitis, corneal ulcers, prosthetic valve endocarditis,
peritonitis and pneumonia [23, 24]. The bacteria are not a
typical component of human flora and have low virulence
[25]. Infection with A. xylosoxidans is widely considered to
be opportunistic, and the source of infection is usually found
to be a contaminated solution [23]. The bacteria can survive in
aqueous environments with minimal nutrients, so it is likely
that the relatively high abundance of these bacteria (0.16–
1.38 % of non-host reads) indicates contamination from the
water or reagent used during sample preparation. It has been
reported previously [26] that sequence-based microbiome
analyses is susceptible to DNA contamination introduced by
molecular biology grade water, PCR reagents and DNA ex-
traction kits.
Alteromonas macleodii is commonly found in temperate or
tropical sea waters [27, 28]. The presence of these Gram-
negative bacteria in humans has not been reported. The pres-
ent study detected high levels of A. macleodii reads across the
samples, accounting for 0.51–11.35 % of non-host reads. It is
suspected that this organism is a contaminant, and its presence
in the NGS dataset should be disregarded.
Bacteriophage (phage) infects and replicates within a bac-
terium and can be present in the study samples through mul-
tiple routes. As Enterobacter is part of normal gut flora, there
is obviously abundant enterobacteria phage in the human
body. Assuming that the phage originated from the patients’
gut, the question is how this phage can escape the gut–blood
barrier. On the other hand, sequencing of phage genomes is an
interesting field of research, with potential uses for phages as
antimicrobials and biocontrol agents for food production [29],
and the phiX174 bacteriophage was the first DNA-based ge-
nome to be sequenced, dating back to 1977 [30]. A previous
study [31] reported enterobacteria phage phiX174 sensu lato
as a common contaminant in NGS datasets from blood
samples.
The presence of hepatitis C virus and dengue virus in all
samples is evidence of cross-contamination from one sample
to another. One sample was collected from a patient with
confirmed hepatitis C virus infection (patient ID# 006); how-
ever, this sample was not sequenced due to insufficient
Fig. 5 Mapping of dengue virus
1 contigs against dengue virus 1
complete genome of 10,735 bp
genomic DNA (NCBI Reference
Sequence: NC_001477.1). The
X-axis represents the size and
position of the genome/contigs in
base pair (bp); the Y-axis
represents the dengue virus 1
reference genome and the dengue
virus 1 contig(s) found in the
sample ID# 5c and 17c1; both are
cDNA samples from patient ID#
005 and 017, respectively
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Table 2 Plausible next-generation sequencing (NGS) diagnoses in patients with undiagnosed fevers
Patient (sample) ID Clinical data Pathology and radiology findings from
conventional investigation at Cairns
Hospital
Plausible NGS diagnosis
002 (2c1, 2c2)a A 59-year-old indigenous man with
diarrhoea. Other active problems:
ischaemic heart disease, pulmonary
hypertension, atrial flutter, type 2
diabetes mellitus, hypertension and
dyslipidaemia. During admission, the
patient commenced gentle rehydration,
ceftriaxone and doxycycline. Ongoing
diarrhoea, dehydration and low blood
pressure led to patient transfer to
intensive care on day 4. He was given
poor prognosis and transferred back to
the ward for comfort measures. He
died on day 18 due to multi-organ
failure.
• Serum urea: 51.7 mmol/l (↑), creatinine:
1000 μmol/l (↑), ALT: 414 U/l (↑),
AST: 1290 U/l (↑), CRP: 102 mg/l (↑)
• Platelet: 60 × 109/l (↓), WBC:
23.2 × 109/l (↑), with neutrophil
predominant (20.69 × 109/l)
• Antinuclear antibody (ANA): (+)
• Blood culture: (−)
• Dengue and hepatitis C serology: (−)
• Faecal microbiology: normal faecal flora
was absent,Clostridium difficile screen
(−), no evidence of parasitic infection
on microscopic examination, and no
Salmonella, Shigella, Yersinia or
Campylobacter grown on culture.
• Chest X-ray: cardiomegaly, no
consolidation in lungs; chest CT: small
pleural effusion; abdomen CT: ascites,
fatty liver, hepatomegaly and
splenomegaly
• Ascites analysis (chemistry and
microbiology): normal
Escherichia coli (57,657 reads,
e-value 4.3E-49).
011 (11)b A 40-year-old man with a 3-day history of
rash, fever, myalgia and nausea,
following recent travel to the Torres
Strait Islands and possible contact with
mites. Erythematous blanching
papules rash were found on trunk,
chest and extremities, and there was an
eschar on his upper left arm. He
showed marked clinical improvement
with doxycycline.
• Serum ALT: 177 U/l (↑), AST: 164 U/l
(↑), CRP: 97 mg/l (↑).
• Platelet: 108 × 109/l (↓), WBC:
3.4 × 109/l (↓).
• Urinalysis: no abnormality detected
• Blood culture: (−)
• Malaria screening: (−)
• Flavivirus, Q fever and Leptospira
serology: (−)
• Spotted fever group (SFG) Rickettsia
and scrub typhus PCR: (−)
Orientia tsutsugamushi (11 reads).
012 (12)b A 31-year-old female from the Atherton
Tablelands presenting with abdominal
pain, nausea, vomiting and
constipation on a background of
inflammatory bowel syndrome. The
patient was given analgesia and was
advised to return to the emergency
department if the pain returned.
• Serum ALT: 545 U/l (↑), AST:
428 U/l (↑)
• ANA: (+)
• Blood culture: (−)
• Hepatitis B and C serology: (−)
• Serology and PCR for CMV, Leptospira
and Q fever: (−)
• Chest X-ray: no abnormality detected
• Abdomen CT: splenomegaly
Nil significant.
014 (14, 14c)a,b A 55-year-old man from Babinda with
fever, myalgia and blanching
maculopapular rash with history of
mosquito bites 2 weeks prior to
presentation. The patient’s wife (ID#
019) concomitantly presented with a
more severe variant of the same illness.
He clinically improved with
ceftriaxone and doxycycline.
• Serum ALT: 63 U/l (↑), AST: 56 U/l (↑)
• Platelet: 122 × 109/l (↓)
• Blood culture: (−)
• Serology for EBV, R. rickettsia,
O. tsutsugamushi, Mycoplasma
pneumoniae, Leptospira, flavivirus:
(−)
• PCR for Rickettsia (SFG and typhus
group), Streptococcus pneumoniae,
Neisseria meningitidis and Leptospira:
(−)
• S. pneumoniae and Legionella antigens
in urine: (−)
Dengue virus (25 reads).
019 (19, 19c1, 19c2)a,b A 57-year-old female transferred from
Babinda hospital andwas the spouse of
patient ID# 014. She had an 8-day
history of fever, rash, retro-orbital
headache, myalgia, malaise, vomiting
and diarrhoea. The patient was
hypotensive at initial presentation to
Babinda hospital and was given
• Serum urea: 43.7 mmol/l (↑), creatinine:
839 μmol/l (↑), ALT: 1170 U/l (↑),
AST: 6160 U/l (↑)
• Platelet: 14 × 109/l (↓), WBC:
35.1 × 109/l (↑) with neutrophil
predominance (30.57 × 109/l)
• Blood culture: (−)
1. EBV (7023 reads).
2. Dengue virus (19 reads).
3. R. conorii (1 read).
4. A. baumannii (2514 reads, e-value
2.0E-68).
5. Listeria monocytogenes (13 reads).
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Table 2 (continued)
Patient (sample) ID Clinical data Pathology and radiology findings from
conventional investigation at Cairns
Hospital
Plausible NGS diagnosis
ceftriaxone, vancomycin and
doxycycline intravenously prior to
transfer. The patient had evidence of
multi-organ failure at transfer to Cairns
Hospital and was intubated. She died
with a diagnosis of septic shock.
• Serology for Leptospira, S. pneumoniae,
EBV, CMV, flavivirus, Q fever,
R. typhi, R. rickettsii,
O. tsutsugamushi, SFG and typhus
group Rickettsia: (−)
• PCR for Leptospira, dengue, scrub
typhus, S. pneumoniae and
N. meningitidis: (−)
• Malaria screen: (−)
027 (27)b A 29-year-old man presented with fever,
generalised weakness, nausea,
vomiting, diarrhoea, dry cough and
headaches after returning from
Thailand, where he had spent some
time in the jungle. The provisional
diagnosis was likely arbovirus
infection. He was given doxycycline to
cover leptospirosis and clinically
improved.
• Serum urea: 11.1 mmol/l (↑), creatinine:
181 μmol/l (↑), ALT: 94 U/l (↑), AST:
68 U/l (↑), CRP: 487 mg/l (↑)
• Platelet: 90 × 109/l (↓), WBC:
15.3 × 109/l (↑)
• Blood culture: (−)
• Faeces culture: no Salmonella, Shigella,
Yersinia, Campylobacter
• Malaria screening: (−)
• Leptospira and dengue serology: (−)
• Respiratory viruses PCR: (−)
1. Dengue virus (11 reads).
2. Salmonella enterica (3 reads).
028 (28)b A 64-year-old man with 4-day fever,
chills, sore eyes and ulcerated mouth.
He had a tick bite recently and had
been on a cruise from Vanuatu through
the Solomon Islands to Papua New
Guinea. He was taking several
medications for high blood pressure
and type 2 diabetes mellitus.
• Serum ALT: 64 U/l (↑), AST: 43 U/l (↑)
• WBC: 0.8 × 109/l (↓), neutrophils
0.02 × 109/l (↓), platelet: 147 × 109/l
(↓)
• Screening for malaria, hepatitis B,
hepatitis C and HIV: (−)
• Serology for CMV, EBV, R. rickettsii,
Leptospira, flavivirus, Q fever,
Brucella, Cryptococcus and
M. pneumoniae: (−)
• Serology for O. tsutsugamushi: weakly
positive (total immunoglobulin: 128)
• PCR for HSV 1 and 2: (−)
• Chest X-ray: clear
• Blood and urine cultures: (−)
The patient’s medical notes were
reviewed and it was found that the
patient had prolonged neutropaenia
(up to 4 weeks). It is likely that the
patient had drug-induced febrile
neutropaenia and the results of
NGS analysis were not considered.
029 (29c)a A 38-year-old female admitted with pos-
sible measles. Initially, the patient had
back pain and fevers without urinary
symptoms. She was started on antibi-
otics for suspected urinary tract infec-
tion. Subsequently, she developed a
rash, which began on her face and
spread to her torso and limbs. She
worked as a housekeeper and had no
exposure to potential allergens or new
chemicals. The patient was admitted
with strict respiratory isolation. On day
1 of admission, the doctor suspected a
small bite on the patient’s back. This
lesion was reviewed by the infectious
diseases team and the impression was
rickettsial in nature. Fevers were
improving with doxycycline.
• Serum ALT: 448 U/l (↑), AST: 519 U/l
(↑)
• Platelet: 99 × 109/l (↓)
• Serology for CMV, EBV, dengue, Ross
River, alphavirus, Barmah Forest,
Sindbis, Chikungunya, Q fever,
Leptospira, Brucella, R. rickettsii,
O. tsutsugamushi, rubella and measles:
(−)
• Measles PCR: (−)
1. Jingmen tick virus (52 reads).
2. R. africae (10 reads).
030 (30)b An 18-year-old man with fever, chills,
headache, muscle pain, joint pain, back
pain, cough, sore throat, nausea and
rash. He had history of a tick bite on
the upper right thigh when camping at
Tinaroo Dam, Atherton Tablelands. He
had been taking doxycycline for
approximately 2 days, as prescribed by
a 24-hour medical centre. The patient
continued on doxycycline for 2 weeks.
• CRP: 37 mg/l (↑)
• Platelet: 125 × 109/l (↓)
• R. rickettsii and O. tsutsugamushi
serology: (−)
1. Jingmen tick virus (32 reads).
2. R. africae (1 read).
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amounts of nucleic acids to enter the amplification step.
Accordingly, it was presumed that the low abundance
(<0.1%) of hepatitis C virus reads in all samples was the result
of contamination during DNA/RNA isolation. As for dengue
virus, although it was detected in all samples, its presence with
high read counts (2.58 %) in sample ID# 5c indicates a true
infection. Dengue virus reads were also present in a relatively
higher proportion (0.01 %) in sample ID# 14 compared to the
rest of the samples. It is possible that patient ID# 014 had a
dengue infection.
Human herpesvirus 4 or Epstein–Barr virus (EBV) is one
of the most common viruses in humans. This virus is wide-
spread internationally, and around 95 % of the human popu-
lation is infected with EBV [32]. Therefore, the presence of
low levels (<1 % of non-host reads) of EBV in all samples is
not surprising. TTMDV has been found in various body
fluids, including saliva and nasopharyngeal aspirates, serum,
urine and stool collected from children with acute respiratory
disease [33]. The frequent detection of TTMDVin our study is
consistent with a previous metagenomic study [34], which
reported that TTMDV constituted the second largest viral
community after torque teno virus in the plasma of healthy
adults.
Although most of the organisms detected in the samples
were presumably contaminants, our data illustrate the high
sensitivity of the deep sequencing approach to reveal micro-
bial diversity within a sample. Previous research [35] had
successfully detected bacterial 16S ribosomal DNA sequences
that were similar to DNA sequences of Riemerella
anatipestifer, Pseudomonas fluorescens, Propionibacterium
acnes, Microbacterium schleiferi, Stenotrophomonas and
Pseudomonas putida in healthy human blood using real-time
PCR and traditional sequencing on an ABI PRISM platform.
These bacterial sequences presumably originated either from
experimental reagents, from the skin during phlebotomy or
from the blood itself. Nonetheless, the findings of the study
raised the possibility that there is a ‘normal’ population of
bacterial DNA sequences in blood that has previously been
considered sterile. The use of NGS in the present study facil-
itated the identification of organisms that might well escape
cultivation because of their low burden in the blood or simply
because they are unculturable. With only 1 % of the microbial
life on earth able to be cultured [36, 37], culture-independent
methods, such as deep sequencing, are clearly required in
order to extend our knowledge of microbial diversity.
In addition to revealing microbial diversity in human
blood, this study provided important information with regards
to the sensitivity and cost-effectiveness of the deep sequenc-
ing approach for fever investigation. We demonstrated that,
with an optimum sample such as that from patient ID# 005,
approximately 15 million PE reads (~2 Gb of data) are suffi-
cient to facilitate the diagnosis of dengue virus. When the
virus load was sufficiently high, de novo assembly permitted
the generation of several contigs corresponding to a nearly
full-length genome, thus confirming the diagnosis of dengue
fever at a cost of AUD $600 for sample processing, library
preparation and deep sequencing.
Bioinformatics analyses are an enormous challenge in
metagenomic studies because, while a variety of tools are
available for analysing sequence data, they require expert
users to assemble them into an effective workflow. The high
volume of data generated by NGS technology is often respon-
sible for considerable delays in achieving a robust diagnosis.
In our experience, bioinformatics analyses of ~2 Gb of raw
sequence data using Kraken can be completed in 1 h. This
speed far exceeds that of conventional BLAST searches,
which may take more than 24 h to complete. To complete
the data analysis as quickly as possible, we used the CLC
Genomic Workbench workflow on reads unclassified by
Kraken to facilitate the identification of infectious agents in
undiagnosed cases (test subjects). In order to validate Kraken
findings, we performed CLC analysis on the raw reads origi-
nating from control subjects in parallel with Kraken analysis.
As Kraken reported an excessive amount (hundreds) of organ-
isms in a single sample, the usefulness of Kraken in the pres-
ent study relates to the rapid screening of pathogens associated
Table 2 (continued)
Patient (sample) ID Clinical data Pathology and radiology findings from
conventional investigation at Cairns
Hospital
Plausible NGS diagnosis
039 (39)b A 57-year-old man with gradual onset of
malaise, vomiting, myalgia, fevers and
white productive cough. The
provisional diagnosis was viral
infection with possible acute renal
failure secondary to viral illness. He
was treated with doxycycline and
Augmentin.
• Serum creatinine: 157 U/l (↑), AST: 40
U/l (↑)
• Chest X-ray was normal
• Leptospira and flavivirus serology: (−)
Dengue virus (27 reads).
a Sequencing was performed on cDNA samples
b Sequencing was performed on DNA samples
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Table 3 Organisms that present in all samples, detected by Kraken analysis
Organism
Sample ID
2c
1
2c
2
5c 10 11 12 14 14
c
17
c1
17
c2
19 19
c1
19
c2
20
c
24
c1
27 28 29
c
30 31
c
32 39
Achromobacter 
xylosoxidans
Alteromonas macleodii
Enterobacteria phage 
phiX174 sensu lato
Escherichia coli
Mycoplasma 
hyopneumoniae
Pandoravirus dulcis
Pandoravirus salinus
Mycoplasma hyorhinis
Elephantid herpesvirus 1
Hyposoter fugitivus
ichnovirus
Pseudomonas fluorescens
Propionibacterium acnes
Human endogenous 
retrovirus K
Yersinia phage phiA1122
Anabaena sp. 90
Bacillus phage SPO1
Organism
Sample ID
2c
1
2c
2
5c 10 11 12 14 14
c
17
c1
17
c2
19 19
c1
19
c2
20
c
24
c1
27 28 29
c
30 31
c
32 39
Ictalurid herpesvirus 1
Pseudomonas aeruginosa
Pseudomonas phage 119X
Pseudomonas sp. TKP
Candidatus Carsonella 
ruddii
Flavobacterium 
psychrophilum
Human herpesvirus 4
Spring beauty latent virus
Enterobacter cloacae
Pseudomonas putida
Gardnerella vaginalis
Mycoplasma gallisepticum
Phaeocystis globosa virus
Pseudomonas phage PaP2
Serratia liquefaciens
Acinetobacter baumannii
Jingmen tick virus
Sorangium cellulosum
Red clover cryptic virus 2
Staphylococcus 
epidermidis
Relative abundance (proportion of organism reads among non-host reads) is shown by graded colour: Bblue^ indicates <0.01 %, Bgreen^ indicates
0.01 % - <0.1 %, Byellow^ indicates 0.1 % - <1 %, Borange^ indicates 1 % - <10 % and Bred^ indicates 10–18.48 %
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with fever. There is a possibility that ambiguous reads may be
mapped tomultiple taxa in theMiniKraken database, resulting
in the detection of organisms that were not actually present in
the sample (false-positive). We suggest that, if the Kraken
program is going to be used for diagnosis, additional steps
are required to filter the true pathogen or pathogen sequences
with clinical relevance. Most importantly, the Kraken findings
are best interpreted in conjunction with reliable clinical infor-
mation and the results of other tests are absolutely necessary to
inform diagnosis.
We showed in Table 1 that performing more complex anal-
yses does not guarantee reliability of results, and may, indeed,
result in failure to detect the true cause of fever (false-nega-
tive). The CLC analysis workflow, which involved pre-
processing and assembly prior to the BLAST search, failed
to detect the true pathogen in 75 % (6/8) of control samples.
Thus, it can be argued that the success of the deep sequencing
approach is more likely to be determined by the sample con-
dition and the sequencing dataset rather than the analysis pipe-
line. It is important to collect samples with high pathogen
load. Ideally, samples should be snap frozen in liquid nitrogen
to preserve the scarce amount of nucleic acids from the path-
ogen. It is equally important to keep the sample processing
steps to a minimum to avoid contamination and prevent
Organism
Sample ID
2c
1
2c
2
5c 10 11 12 14 14
c
17
c1
17
c2
19 19
c1
19
c2
20
c
24
c1
27 28 29
c
30 31
c
32 39
Thermoanaerobacter 
wiegelii
Alcelaphine herpesvirus 2
Caldicellulosiruptor 
kronotskyensis
Dill cryptic virus 2
Halovivax ruber
Hepatitis C virus
Mannheimia haemolytica
Cercopithecine herpesvirus 
2
Dengue virus 1
Lawsonia intracellularis
Ornithobacterium 
rhinotracheale
Candidatus Sulcia muelleri
Glypta fumiferanae
ichnovirus
Hop trefoil cryptic virus 2
Torque teno midi virus 2
Verminephrobacter 
eiseniae
Anaplasma centrale
Caldanaerobacter 
subterraneus
Organism
Sample ID
2c
1
2c
2
5c 10 11 12 14 14
c
17
c1
17
c2
19 19
c1
19
c2
20
c
24
c1
27 28 29
c
30 31
c
32 39
Carp picornavirus 1
Cotesia congregata 
bracovirus
Cynomolgus macaque 
cytomegalovirus strain 
Ottawa
Dickeya phage RC-2014
Mouse astrovirus M-
52/USA/2008
Rickettsia africae
Salivirus FHB
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further degradation of the nucleic acids. Providing negative
controls and running ‘blanks’ in the same sequencing lanes as
the actual samples can make the interpretation of the results
easier, as the contaminating agents can be immediately iden-
tified and ruled out from the NGS dataset. Finally, the choice
of NGS platform contributes to the success of pathogen detec-
tion. The long reads produced by the 454 platform increase the
specificity of pathogen identification by facilitating the dis-
crimination of pathogen reads from hosts or endogenous flora.
Although Illumina platforms generate short reads (currently
up to 2×150 bp for the HiSeq and Genome Analyzer II and
2×300 bp for the MiSeq), this platform can generate sequenc-
ing data much faster than the 454 platform, thus providing
sufficient read depth or number of sequence reads generated
per run to detect pathogens with a high degree of sensitivity.
The development of single-molecule sequencing (also
known as third-generation sequencing), such as nanopore se-
quencing or MinION (Oxford Nanopore Technologies), is
highly promising; this pocket-sized genome sequencer can
generate longer reads (tens of kilobases) at a cost comparable
to that of currently available NGS instruments [38]. Another
advantage of this portable DNA sequencer over NGS is its
ability to perform real-time sequence analysis, which is highly
valuable for providing results rapidly. The downside of
nanopore sequencing is that the technology currently requires
micrograms of DNA/cDNA input. Two recent studies [39, 40]
reported disadvantages of MinION sequencing, including
higher error rates (10–30 %) and relatively lower throughput
(<100,000 reads per cell) compared with NGS.
In conclusion, the deep sequencing approach facilitated the
identification of infectious agents associated with AUF as well
as other organisms present in human blood. We identified chal-
lenges in conducting a deep sequencing approach for routine
investigation of fever. Future improvements in sequencing plat-
forms are needed to provide longer reads and enable sequenc-
ing from smaller amounts of input material. The development
of bioinformatics tools should be directed towards user-friendly
options and the means to provide answers in clinically relevant
timeframes (e.g. within hours of sample receipt). Recent ad-
vancement in sequencing technologies and bioinformatics
analyses provides a positive outlook for the application of the
deep sequencing approach to facilitate the diagnosis of AUFs.
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